Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study

Authors Chung PC, Chen HP, Lin JR, Liu FC, Yu HP

Received 22 September 2016

Accepted for publication 27 October 2016

Published 14 December 2016 Volume 2016:12 Pages 1855—1860

DOI https://doi.org/10.2147/TCRM.S123011

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Professor Deyun Wang

Peter Chi-Ho Chung,1,2 Hsiu-Pin Chen,1,2 Jr-Rung Lin,3,4 Fu-Chao Liu,1,2 Huang-Ping Yu1,2

1Department of Anesthesiology, Chang Gung Memorial Hospital, 2College of Medicine, 3Clinical Informatics and Medical Statistics Research Center, 4Graduate Institute of Clinical Medicine, Chang Gung University, Taoyuan, Taiwan

Purpose: The purpose of this study was to assess whether preoperative chronic renal failure (CRF) affects the rates of postoperative complications and survival after liver transplantation.
Methods: This population-based retrospective cohort study included 2,931 recipients of liver transplantation performed between 1998 and 2012, enrolled from the Taiwan National Health Insurance Research Database. Patients were divided into two groups, based on the presence or absence of preoperative CRF.
Results: The overall estimated survival rate of liver transplantation recipients (LTRs) with preoperative CRF was significantly lower than that of patients without preoperative CRF (P=0.0085). There was no significant difference between the groups in terms of duration of intensive care unit stay, total hospital stay, bacteremia, postoperative bleeding, and pneumonia during hospitalization. Long-term adverse effects, including cerebrovascular disease and coronary heart disease, were not different between patients with versus without CRF.
Conclusion:
These findings suggest that LTRs with preoperative CRF have a higher rate of mortality.

Keywords: chronic renal failure, cohort study, survival rate, liver transplantation, population-based study

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation

Liu FC, Ting PC, Lin JR, Yu HP

Therapeutics and Clinical Risk Management 2017, 13:1391-1398

Published Date: 13 October 2017

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients

Liu FC, Lin HT, Lin JR, Yu HP

Therapeutics and Clinical Risk Management 2017, 13:1043-1051

Published Date: 18 August 2017